Ying Huang

Ying Huang is an Associate Professor in the Department of Accounting at the Jindal School of Management (JSOM), University of Texas at Dallas. Her research focuses on nanotechnology and biomedical applications, particularly in renal physiology, drug delivery systems, and nanomedicine. Despite her departmental affiliation in Accounting, her work bridges engineering and medicine, addressing challenges in nanoparticle design for kidney-targeted therapies, imaging, and toxicity analysis.

Her research interests include the development of renal-clearable nanocarriers, photothermal therapy agents, and luminescent nanoparticles for non-invasive diagnostics. Key areas of exploration are kidney transport mechanisms, surface charge effects on nanoparticle interactions, and excretion pathways. She has pioneered studies on gold, silver, and hybrid nanoparticles for biomedical applications, emphasizing their role in overcoming physiological barriers for targeted drug delivery and imaging.

Publications from 2018–2024 highlight her contributions to understanding nanoparticle behavior in diseased states (e.g., rhabdomyolysis, cancer), optimizing drug delivery via PEGylation and ligand-density modulation, and advancing photothermal cancer treatments. Her work integrates material science, cell biology, and clinical diagnostics, with applications in kidney disease modeling, hepatotoxicity monitoring, and sensor technology.

No scientific awards or grants are explicitly mentioned in the provided texts. She advises no listed students, though her interdisciplinary research likely involves graduate trainees. Her lab’s focus aligns with biomedical nanotechnology, targeting translational applications in diagnostics and therapy.